Tristel plc
("Tristel" or the "Company")
Director Option Grant
Tristel plc (AIM: TSTL), the manufacturer of infection prevention products, announces that on 22 January 2025 it granted a total of 127,468 new share options (the "Options") over ordinary shares of 1 pence each ("Ordinary Shares") under the new Long Term Incentive Plan ("LTIP") in the Company, to two directors as follows:
Director's name |
Position |
Number of Options granted |
Aggregate number of options post grant |
Current total beneficial holding of Ordinary Shares |
Current holding as a % of Issued share capital |
Matt Sassone |
CEO |
77,004 |
77,004 |
0 |
0 |
Liz Dixon |
CFO |
50,464 |
50,464 |
150,000 |
0.31 |
Terms of the new LTIP
The performance targets for the LTIP awards will be 50% based on earning per share (EPS) targets and 50% based on relative total shareholder return (TSR) versus the constituents of the AIM 100 as at the grant of the awards as follows:
50% of Initial awards |
50% of Initial awards |
|
||
EPS FY 26/27 |
% of EPS Part that Vests |
Relative TSR measured over 3 years from grant |
% of TSR Part that Vests |
|
Less than 18p |
0% |
Below median |
0% |
|
Between 18p and 25p |
Pro-rata 25% to 100% |
Between median and upper quartile |
Pro-rata 25% to 100% |
|
25p or better |
100% |
Upper quartile or above |
100% |
|
This announcement was deemed by the company to contain inside information as stipulated under the Market Abuse Regulations (EU) no. 596/2014 as they form part of UK domestic law by virtue of the European Union (withdrawal) Act 2018. With the publication of this announcement, this information is now considered to be in the public domain.
For further information please contact:
Tristel plc |
Via Walbrook PR |
|
Matt Sassone, Chief Executive Officer |
||
Liz Dixon, Chief Financial Officer |
|
|
|
|
|
Walbrook PR Ltd |
Tel: 020 7933 8780 or tristel@walbrookpr.com |
|
Paul McManus |
Mob: 07980 541 893 |
|
Lianne Applegarth |
Mob: 07584 391303 |
|
|
|
|
Cavendish Capital Markets Limited |
Tel: 020 7220 0500 |
|
Geoff Nash / Camilla Hume / Trisyia Jamaludin (Corporate Finance) |
|
|
Sunila de Silva (ECM) Louise Talbot (Sales) |
|
|
About Tristel plc
Tristel plc is a global infection prevention company focussed on the manufacture and supply of products using its unique proprietary chlorine dioxide (ClO2) chemistry. The Company is a market leader in manual decontamination of medical devices, supplying hospitals under the Tristel brand, and under the Cache brand provides products for sporicidal surface disinfection, in a format which is a sustainable alternative to commonly used pre-wetted plastic wipes.
Tristel's head office and manufacturing facility is located in Snailwell, near Cambridge, and operates globally employing approximately 250 people across 14 subsidiaries selling into 40 countries.
The Company has been listed on the London Stock Exchange's AIM market since 2005 (AIM: TSTL).
For more information about Tristel's product range please visit: https://tristel.com
The information set out below is provided in accordance with the requirements of Article 19(3) of the EU Market Abuse Regulation No 596/2014 which forms part of UK Law by virtue of the European Union (Withdrawal) Act 2018.
1. |
Details of the person discharging managerial responsibilities / person closely associated |
|
a) |
Name |
Matthew Sassone |
2. |
Reason for the Notification |
|
a) |
Position/status |
CEO |
b) |
Initial notification/Amendment |
Initial notification |
3. |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|
a) |
Name |
Tristel plc |
b) |
LEI |
2138009DZ4LH9CZGF662 |
4. |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|
a) |
Description of the Financial instrument, type of instrument |
Ordinary shares of 1p each |
Identification code |
GB00B07RVT99 |
|
b) |
Nature of the transaction |
Grant of options |
c) |
Price(s) and volume(s) |
1pence, 77,004 shares
|
d) |
Aggregated information: · Aggregated volume · Price |
See above
|
e) |
Date of the transaction |
22 January 2025 |
f) |
Place of the transaction |
Outside of a trading venue |
1. |
Details of the person discharging managerial responsibilities / person closely associated |
|
a) |
Name |
Elizabeth Dixon |
2. |
Reason for the Notification |
|
a) |
Position/status |
CFO |
b) |
Initial notification/Amendment |
Initial notification |
3. |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|
a) |
Name |
Tristel plc |
b) |
LEI |
2138009DZ4LH9CZGF662 |
4. |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|
a) |
Description of the Financial instrument, type of instrument |
Ordinary shares of 1p each |
Identification code |
GB00B07RVT99 |
|
b) |
Nature of the transaction |
Grant of options |
c) |
Price(s) and volume(s) |
1 pence, 50,464 shares
|
d) |
Aggregated information: · Aggregated volume · Price |
See above
|
e) |
Date of the transaction |
22 January 2025 |
f) |
Place of the transaction |
Outside of a trading venue |